Panel Discussion: Empowering Combination Strategies to Target RAS Mutant Cancers: The Future of Oncology Therapy

Time: 2:00 pm
day: Day Two


  • What are the key factors to consider ensuring successful translation from discovery to clinic?
  • The importance of moving beyond G12C – with the abundance of research surrounding G12C mutation, how and why should we be pushing for new avenues to explore?
  • Technology, platforms & collaborations – what does the RAS community need in order to progress and produce effective, quality and safe RAS mutant cancer therapies?